PPI Treatment for Pediatric Gastroesophageal Reflux Disease (GERD)

Indications for PPI Use

For a 12-year-old with GERD, PPIs should only be used when there are clear gastrointestinal symptoms such as heartburn, epigastric pain, or recurrent regurgitation—not for isolated reflux symptoms without these features, as recommended by the American College of Chest Physicians 1
The American College of Chest Physicians recommends verifying the presence of heartburn, epigastric pain, or regurgitation before initiating PPI therapy, and ruling out other causes such as eosinophilic esophagitis, functional dyspepsia, or H. pylori infection 1
The American College of Chest Physicians advises against initiating PPI therapy for chronic cough or respiratory symptoms alone without typical GERD symptoms, or for suspected "silent reflux" without documented gastrointestinal complaints 1
The American College of Chest Physicians suggests that PPI therapy may be considered when symptoms significantly impair quality of life and other causes have been excluded 1

The American College of Chest Physicians recommends dietary changes, such as limiting fat to <45g/24h, avoiding coffee, tea, soda, chocolate, mints, citrus, and tomatoes, alongside PPI therapy 2, 3
Elevating the head of the bed, avoiding tight clothing, and limiting vigorous exercise that increases intra-abdominal pressure are also recommended by the American College of Chest Physicians as lifestyle modifications to be used alongside PPI therapy 2, 3

The American College of Chest Physicians recommends combining PPI therapy with dietary modifications and lifestyle changes for optimal outcomes 2, 3
Consideration of prokinetic therapy is recommended by the American College of Chest Physicians if symptoms persist despite adequate acid suppression 2, 3
The American College of Chest Physicians advises against relying on acid suppression alone and recommends combining it with dietary modifications and lifestyle changes for optimal outcomes 2, 3

The American College of Chest Physicians recommends referral to pediatric gastroenterology if symptoms remain refractory despite 8-12 weeks of optimized therapy, or if alarm symptoms such as dysphagia, weight loss, or GI bleeding are present 1

The American Academy of Pediatrics recommends administering lansoprazole approximately 30 minutes before meals for optimal acid suppression 4
The American College of Gastroenterology suggests that treatment should be limited to 8-12 weeks initially, as lansoprazole has not been studied beyond 12 weeks in this age group, and consider referral to pediatric gastroenterology if symptoms remain refractory despite dose optimization 4

The American Academy of Pediatrics warns that prolonged PPI use (>2.5 years) may cause enterochromaffin cell hyperplasia in up to 50% of children, and is associated with increased risk of lower respiratory tract infections, vitamin B12 deficiency, and bone fractures 5, 6
The National Institute of Child Health and Human Development advises against using lansoprazole in infants <1 year, as it has been shown to be no more effective than placebo in infants while significantly increasing serious adverse events, particularly lower respiratory tract infections (OR 6.56; 95% CI 1.18-26.25) 5, 7, 8

The American College of Gastroenterology recommends that if lansoprazole is unavailable or not tolerated, omeprazole (0.7-3.3 mg/kg/day) or esomeprazole (10-20 mg once daily based on weight) are FDA-approved alternatives with similar efficacy profiles 4, 6
The American Gastroenterological Association suggests that omeprazole has been shown to be more effective than H2-receptor antagonists for symptom relief and healing of erosive esophagitis 4